Finasteride
"Finasteride" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An orally active 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE inhibitor. It is used as a surgical alternative for treatment of benign PROSTATIC HYPERPLASIA.
| Descriptor ID |
D018120
|
| MeSH Number(s) |
D04.808.054.079.500 D04.808.925.100.250
|
| Concept/Terms |
Eucoprost- Eucoprost
- Frosst Iberica Brand of Finasteride
Proscar- Proscar
- MSD Chibropharm Brand of Finasteride
- Merck Frosst Brand 2 of Finasteride
- Merck Sharp & Dhome Brand 2 of Finasteride
- Cahill May Roberts Brand of Finasteride
- Merck Brand 2 of Finasteride
Propecia- Propecia
- Propeshia
- Merck Brand 1 of Finasteride
- Merck Sharp & Dohme Brand 1 of Finasteride
- MSD Brand of Finasteride
- Merck Frosst Brand 1 of Finasteride
|
Below are MeSH descriptors whose meaning is more general than "Finasteride".
Below are MeSH descriptors whose meaning is more specific than "Finasteride".
This graph shows the total number of publications written about "Finasteride" by people in UAMS Profiles by year, and whether "Finasteride" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2023 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2005 | 0 | 2 | 2 |
| 2002 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Finasteride" by people in Profiles over the past ten years.
-
Masson R, Shih T, Jeong C, Shi VY, Hsiao JL. Hormonal Treatments in Hidradenitis Suppurativa: A Systematic Review. J Drugs Dermatol. 2023 Aug 01; 22(8):785-794.
-
Kaplan SA, Lee JY, Meehan AG, Kusek JW. Time Course of Incident Adverse Experiences Associated with Doxazosin, Finasteride and Combination Therapy in Men with Benign Prostatic Hyperplasia: The MTOPS Trial. J Urol. 2016 06; 195(6):1825-9.